OpGen Announces Partial Adjournment of Annual Meeting for Proposal 2 with All Other Proposals Passed

NEXT STORY
Innate Pharma Presents New Data on Next-Generation NK Cell Engager Platform at FOCIS 2021 Annual Meeting
PREV STORY
Plus Therapeutics to Participate in BIO Digital Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

DUBLIN, Ireland, Dec. 05, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical ...

author_avatar
NASDAQ Market News

Arcturus Therapeutics Hosts Ribbon Cutting Ceremony for its Research and Development Facility

SAN DIEGO, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT), a ...

author_avatar
NASDAQ Market News

Cancer Genetics, Inc. Announces 25th Contract Win to Provide Testing & Diagnostic Services for Combination Immuno-Oncology Clinical Trial

Nearly half of the 50+ Immuno-Oncology Clinical Trials that CGI is supporting are combination ...

author_avatar
NASDAQ Market News